Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Roseoside, a flavonoid glycoside, is a natural chemical compound derived from various plant species, predominantly from the Rosaceae family, which includes numerous rose species. It is recognized for its antioxidant, anti-inflammatory, and antimicrobial properties, which contribute to its traditional medicinal applications in treating a range of diseases. Despite its therapeutic potential, there is a need for more extensive research to fully understand its pharmacological effects, potential toxicity, and mechanisms of action.

54835-70-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 2-Cyclohexen-1-one,4-[(1E,3R)-3-(â-Dglucopyranosyloxy)- 1-butenyl]-4-hydroxy-3,5,- 5-trimethyl-,(4S)-

    Cas No: 54835-70-0

  • USD $ 1.9-2.9 / Gram

  • 100 Gram

  • 1000 Metric Ton/Month

  • Chemlyte Solutions
  • Contact Supplier
  • 54835-70-0 Structure
  • Basic information

    1. Product Name: roseoside
    2. Synonyms: -Dglucopyranosyloxy)- 1-butenyl]-4-hydroxy-3,5,- 5-triMethyl-,(4S)-;roseoside;(4S)-3-Methyl-4-hydroxy-4-[(1E,3R)-3-(β-D-glucopyranosyloxy)-1-butenyl]-5,5-dimethyl-2-cyclohexene-1-one;(S)-4-[(R,E)-3-(β-D-Glucopyranosyloxy)-1-butenyl]-4-hydroxy-3,5,5-trimethyl-2-cyclohexen-1-one;[(1R,2E)-1-Methyl-3-[(1S)-1-hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexenyl]-2-propenyl]β-D-glucopyranoside;Roseoside A;Vomifoliol 9-glucoside;2-Cyclohexen-1-one,4-[(1E,3R)-3-(â
    3. CAS NO:54835-70-0
    4. Molecular Formula: C19H30O8
    5. Molecular Weight: 386.4367
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 54835-70-0.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 595.9±50.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.32±0.1 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. PKA: 12.52±0.60(Predicted)
    10. CAS DataBase Reference: roseoside(CAS DataBase Reference)
    11. NIST Chemistry Reference: roseoside(54835-70-0)
    12. EPA Substance Registry System: roseoside(54835-70-0)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 54835-70-0(Hazardous Substances Data)

54835-70-0 Usage

Uses

Used in Traditional Medicine:
Roseoside is used as a therapeutic agent for its antioxidant, anti-inflammatory, and antimicrobial properties, which contribute to the treatment of various diseases in traditional medicine.
Used in Pharmaceutical Industry:
Roseoside is used as a pharmaceutical ingredient for its diverse therapeutic properties, including its potential as an antioxidant, anti-inflammatory, and antimicrobial agent, to develop new drugs for treating various health conditions.
Used in Cosmetics Industry:
Roseoside is used as an active ingredient in cosmetics for its antioxidant and anti-inflammatory properties, which can help protect the skin from environmental damage and reduce inflammation, promoting a healthier and more youthful appearance.
Used in Food and Beverage Industry:
Roseoside is used as a natural preservative and flavor enhancer in the food and beverage industry, thanks to its antimicrobial properties and unique taste profile.

Check Digit Verification of cas no

The CAS Registry Mumber 54835-70-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,4,8,3 and 5 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 54835-70:
(7*5)+(6*4)+(5*8)+(4*3)+(3*5)+(2*7)+(1*0)=140
140 % 10 = 0
So 54835-70-0 is a valid CAS Registry Number.

54835-70-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name (2R,3E)-4-[(1S)-1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl ]-3-buten-2-yl β-D-glucopyranoside

1.2 Other means of identification

Product number -
Other names roseoside II

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:54835-70-0 SDS

54835-70-0Synthetic route

(6S,9R)-9-(4,6-O-isopropylidene-β-D-glucopyranosyl)oxy-6-hydroxy-3-oxo-α-ionol

(6S,9R)-9-(4,6-O-isopropylidene-β-D-glucopyranosyl)oxy-6-hydroxy-3-oxo-α-ionol

(6S,9R)-roseoside
54835-70-0

(6S,9R)-roseoside

Conditions
ConditionsYield
With water; pyridinium p-toluenesulfonate In ethanol at 20 - 50℃; for 22h;99%
2,2-Dimethyl-propionic acid (2R,3R,4S,5R,6R)-4,5-bis-(2,2-dimethyl-propionyloxy)-6-(2,2-dimethyl-propionyloxymethyl)-2-[(E)-(R)-3-((S)-1-hydroxy-2,6,6-trimethyl-4-oxo-cyclohex-2-enyl)-1-methyl-allyloxy]-tetrahydro-pyran-3-yl ester
863032-39-7

2,2-Dimethyl-propionic acid (2R,3R,4S,5R,6R)-4,5-bis-(2,2-dimethyl-propionyloxy)-6-(2,2-dimethyl-propionyloxymethyl)-2-[(E)-(R)-3-((S)-1-hydroxy-2,6,6-trimethyl-4-oxo-cyclohex-2-enyl)-1-methyl-allyloxy]-tetrahydro-pyran-3-yl ester

(6S,9R)-roseoside
54835-70-0

(6S,9R)-roseoside

Conditions
ConditionsYield
With methanol; lithium hydroxide at 20℃; for 24h;83%
tetraacetylroseoside
54619-16-8

tetraacetylroseoside

(6S,9R)-roseoside
54835-70-0

(6S,9R)-roseoside

Conditions
ConditionsYield
With sodium methylate In methanol for 2h; Ambient temperature;7 mg
With sodium methylate
vomifoliol acetate
84551-74-6

vomifoliol acetate

(6S,9R)-roseoside
54835-70-0

(6S,9R)-roseoside

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 85 percent / NaOMe; MeOH / 1.5 h / 20 °C
2: 57 percent / N,N-tetramethylurea; AgOTf / CH2Cl2 / 1.83 h / 0 - 20 °C
3: 83 percent / LiOH*H2O; MeOH / 24 h / 20 °C
View Scheme
Acetic acid (E)-(R)-1-methyl-3-((1S,6R)-2,2,6-trimethyl-4-oxo-7-oxa-bicyclo[4.1.0]hept-1-yl)-allyl ester
437711-51-8

Acetic acid (E)-(R)-1-methyl-3-((1S,6R)-2,2,6-trimethyl-4-oxo-7-oxa-bicyclo[4.1.0]hept-1-yl)-allyl ester

(6S,9R)-roseoside
54835-70-0

(6S,9R)-roseoside

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 446 mg / p-TsOH*H2O / benzene / 17 h / 20 °C
2: 85 percent / NaOMe; MeOH / 1.5 h / 20 °C
3: 57 percent / N,N-tetramethylurea; AgOTf / CH2Cl2 / 1.83 h / 0 - 20 °C
4: 83 percent / LiOH*H2O; MeOH / 24 h / 20 °C
View Scheme
Acetic acid (E)-(R)-3-((1S,4S,6R)-4-hydroxy-2,2,6-trimethyl-7-oxa-bicyclo[4.1.0]hept-1-yl)-1-methyl-allyl ester
863032-35-3

Acetic acid (E)-(R)-3-((1S,4S,6R)-4-hydroxy-2,2,6-trimethyl-7-oxa-bicyclo[4.1.0]hept-1-yl)-1-methyl-allyl ester

(6S,9R)-roseoside
54835-70-0

(6S,9R)-roseoside

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: Dess-Martin periodinane / CH2Cl2 / 1.5 h / 20 °C
2: 446 mg / p-TsOH*H2O / benzene / 17 h / 20 °C
3: 85 percent / NaOMe; MeOH / 1.5 h / 20 °C
4: 57 percent / N,N-tetramethylurea; AgOTf / CH2Cl2 / 1.83 h / 0 - 20 °C
5: 83 percent / LiOH*H2O; MeOH / 24 h / 20 °C
View Scheme
(E)-(R)-4-[(R)-4-(tert-Butyl-dimethyl-silanyloxy)-2,6,6-trimethyl-cyclohex-1-enyl]-but-3-en-2-ol
863032-50-2

(E)-(R)-4-[(R)-4-(tert-Butyl-dimethyl-silanyloxy)-2,6,6-trimethyl-cyclohex-1-enyl]-but-3-en-2-ol

(6S,9R)-roseoside
54835-70-0

(6S,9R)-roseoside

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1: 90 percent / pyridine / 3 h / 20 °C
2: 30 percent / m-chloroperoxybenzoic acid / CH2Cl2 / 1 h / 20 °C
3: 97 percent / HF*Py / tetrahydrofuran / 0.25 h / 0 °C
4: Dess-Martin periodinane / CH2Cl2 / 1.5 h / 20 °C
5: 446 mg / p-TsOH*H2O / benzene / 17 h / 20 °C
6: 85 percent / NaOMe; MeOH / 1.5 h / 20 °C
7: 57 percent / N,N-tetramethylurea; AgOTf / CH2Cl2 / 1.83 h / 0 - 20 °C
8: 83 percent / LiOH*H2O; MeOH / 24 h / 20 °C
View Scheme
Acetic acid (E)-(R)-3-[(R)-4-(tert-butyl-dimethyl-silanyloxy)-2,6,6-trimethyl-cyclohex-1-enyl]-1-methyl-allyl ester
872003-41-3

Acetic acid (E)-(R)-3-[(R)-4-(tert-butyl-dimethyl-silanyloxy)-2,6,6-trimethyl-cyclohex-1-enyl]-1-methyl-allyl ester

(6S,9R)-roseoside
54835-70-0

(6S,9R)-roseoside

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: 30 percent / m-chloroperoxybenzoic acid / CH2Cl2 / 1 h / 20 °C
2: 97 percent / HF*Py / tetrahydrofuran / 0.25 h / 0 °C
3: Dess-Martin periodinane / CH2Cl2 / 1.5 h / 20 °C
4: 446 mg / p-TsOH*H2O / benzene / 17 h / 20 °C
5: 85 percent / NaOMe; MeOH / 1.5 h / 20 °C
6: 57 percent / N,N-tetramethylurea; AgOTf / CH2Cl2 / 1.83 h / 0 - 20 °C
7: 83 percent / LiOH*H2O; MeOH / 24 h / 20 °C
View Scheme
Acetic acid (E)-(R)-3-[(1S,4S,6R)-4-(tert-butyl-dimethyl-silanyloxy)-2,2,6-trimethyl-7-oxa-bicyclo[4.1.0]hept-1-yl]-1-methyl-allyl ester
863032-34-2

Acetic acid (E)-(R)-3-[(1S,4S,6R)-4-(tert-butyl-dimethyl-silanyloxy)-2,2,6-trimethyl-7-oxa-bicyclo[4.1.0]hept-1-yl]-1-methyl-allyl ester

(6S,9R)-roseoside
54835-70-0

(6S,9R)-roseoside

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: 97 percent / HF*Py / tetrahydrofuran / 0.25 h / 0 °C
2: Dess-Martin periodinane / CH2Cl2 / 1.5 h / 20 °C
3: 446 mg / p-TsOH*H2O / benzene / 17 h / 20 °C
4: 85 percent / NaOMe; MeOH / 1.5 h / 20 °C
5: 57 percent / N,N-tetramethylurea; AgOTf / CH2Cl2 / 1.83 h / 0 - 20 °C
6: 83 percent / LiOH*H2O; MeOH / 24 h / 20 °C
View Scheme
blumenol A
23526-45-6

blumenol A

(6S,9R)-roseoside
54835-70-0

(6S,9R)-roseoside

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 57 percent / N,N-tetramethylurea; AgOTf / CH2Cl2 / 1.83 h / 0 - 20 °C
2: 83 percent / LiOH*H2O; MeOH / 24 h / 20 °C
View Scheme
2,3,4,6-tetra-O-pivaloyl-α-D-glucopyranosyl bromide
81058-27-7

2,3,4,6-tetra-O-pivaloyl-α-D-glucopyranosyl bromide

(6S,9R)-roseoside
54835-70-0

(6S,9R)-roseoside

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 57 percent / N,N-tetramethylurea; AgOTf / CH2Cl2 / 1.83 h / 0 - 20 °C
2: 83 percent / LiOH*H2O; MeOH / 24 h / 20 °C
View Scheme
(R)-4-[(R)-4-(tert-Butyl-dimethyl-silanyloxy)-2,6,6-trimethyl-cyclohex-1-enyl]-but-3-yn-2-ol
322474-92-0

(R)-4-[(R)-4-(tert-Butyl-dimethyl-silanyloxy)-2,6,6-trimethyl-cyclohex-1-enyl]-but-3-yn-2-ol

(6S,9R)-roseoside
54835-70-0

(6S,9R)-roseoside

Conditions
ConditionsYield
Multi-step reaction with 9 steps
1: 93 percent / LiAlH4 / tetrahydrofuran / 1 h / 60 °C
2: 90 percent / pyridine / 3 h / 20 °C
3: 30 percent / m-chloroperoxybenzoic acid / CH2Cl2 / 1 h / 20 °C
4: 97 percent / HF*Py / tetrahydrofuran / 0.25 h / 0 °C
5: Dess-Martin periodinane / CH2Cl2 / 1.5 h / 20 °C
6: 446 mg / p-TsOH*H2O / benzene / 17 h / 20 °C
7: 85 percent / NaOMe; MeOH / 1.5 h / 20 °C
8: 57 percent / N,N-tetramethylurea; AgOTf / CH2Cl2 / 1.83 h / 0 - 20 °C
9: 83 percent / LiOH*H2O; MeOH / 24 h / 20 °C
View Scheme
6'-O-caffeoyl-(6S,9R)-roseoside

6'-O-caffeoyl-(6S,9R)-roseoside

A

D-glucose
50-99-7

D-glucose

B

blumenol A
23526-45-6

blumenol A

C

caffeic acid
331-39-5

caffeic acid

D

(6S,9R)-roseoside
54835-70-0

(6S,9R)-roseoside

Conditions
ConditionsYield
With cellulase In water at 37℃; for 12h; Enzymatic reaction;A n/a
B 0.5 mg
C n/a
D 1 mg
(6S,9R)-roseoside
54835-70-0

(6S,9R)-roseoside

A

D-glucose
50-99-7

D-glucose

B

blumenol A
23526-45-6

blumenol A

Conditions
ConditionsYield
With water at 37℃; for 2h; enzyme: hesperidinase;A 11 mg
B 10 mg
(6S,9R)-roseoside
54835-70-0

(6S,9R)-roseoside

6,9-dihydroxymegastigma-4,7-dien-3-one
23526-45-6, 24427-77-8, 50763-72-9, 50763-73-0

6,9-dihydroxymegastigma-4,7-dien-3-one

Conditions
ConditionsYield
In water for 16h; Ambient temperature; β-glucosidase;1.2 mg
(6S,9R)-roseoside
54835-70-0

(6S,9R)-roseoside

tetraacetylroseoside
54619-16-8

tetraacetylroseoside

Conditions
ConditionsYield
12 mg
acetic anhydride
108-24-7

acetic anhydride

(6S,9R)-roseoside
54835-70-0

(6S,9R)-roseoside

tetraacetylroseoside
54619-16-8

tetraacetylroseoside

Conditions
ConditionsYield
In pyridine for 24h; Ambient temperature;17 mg
(6S,9R)-roseoside
54835-70-0

(6S,9R)-roseoside

blumenol A
23526-45-6

blumenol A

Conditions
ConditionsYield
With β-glucosidase at 37℃; for 48h; pH 5.0 (acetate buffer);11 mg

54835-70-0Upstream product

54835-70-0Relevant articles and documents

A simple synthesis of four stereoisomers of roseoside and their inhibitory activity on leukotriene release from mice bone marrow-derived cultured mast cells

Yajima, Arata,Oono, Yutaka,Nakagawa, Ryusuke,Nukada, Tomoo,Yabuta, Goro

, p. 189 - 194 (2009)

Four stereoisomers of roseoside (vomifoliol glucosides) were synthesized using glucose as a chiral resolving reagent. The four synthetic stereoisomers exhibited inhibitory activity on leukotriene release from mouse bone marrow-derived cultured mast cells (BMCMC). The (6S)-isomers of roseoside were about twice as active as (6R)-isomers.

Characterization of caffeoylglucoside derivatives and hypouricemic activity of the ethyl acetate fraction from Aster glehni

Son, Min Jeoung,Jin, Changbae,Lee, Yong Sup,Lee, Jae Yeol,Kim, Hyoung Ja

, p. 503 - 512 (2015/05/06)

In the search for xanthine oxidase (XOD) inhibitors as anti-gout agents from natural products, various chromatographic separations of the ethyl acetate-soluble fraction of Aster glehni (AGEF) led to the isolation of five new caffeoylglucoside derivatives, namely 6′-O-caffeoyl-(6S,9R)-roseoside (1), 6′-O-caffeoylampelopsisionoside (2), 6′-O-caffeoylsonchuinoside C (3), 6′-O-caffeoyldihydrosyringin (4), and (2E)-2-methyl-but-2-ene-1,4-diol-6′-O-caffeoyl-1-O-β-glucopyranoside (glehnoside, 5), together with 13 known compounds. The absolute stereochemistry of the 6′-O-caffeoylsonchuinoside C (3) was established with the help of spectroscopic analyses, enzymatic hydrolysis, and Mosher's method, as well as in comparison with literature data. All isolated substances were determined for their inhibitory activities on uric acid production by the xanthine/XOD system. Among them, 4,5-O-dicaffeoylquinic acid methyl ester (12) showed the most potent inhibitory activity with an IC50 value of 2.6 ± 0.1 μM, which was comparable to that of allopurinol used as a positive control. Furthermore, hypouricemic effects of AGEF were assessed by measuring serum uric acid levels 3 h after potassium oxonate treatment (250 mg/kg, i.p.) to induce hyperuricemia in rats. When preadministered orally once a day at doses of 50, 100, and 300 mg/kg for 7 days, AGEF reduced the potassium oxonate-induced elevated serum uric acid level by 15.4, 39.8, and 32.3%, respectively. The results suggest that AGEF has the potential to be a new source of agents for the prevention and/or treatment of hyperuricemia and gout.

Synthesis of optically active vomifoliol and roseoside stereoisomers

Yamano, Yumiko,Ito, Masayoshi

, p. 541 - 546 (2007/10/03)

A synthesis of optically active vomifoliol stereoisomers 1-4 and their glucosides, roseoside stereoisomers 5-8, was accomplished via α-acetylenic alcohol 11a or 11b effectively prepared by an asymmetric transfer hydrogenation of α,β-acetylenic ketone 10. Simultaneous separation of these stereoisomers by HPLC was also perfomed.

Glycosidically Bound Norisoprenoids from Vitis vinifera Cv. Riesling Leaves

Skouroumounis, George K.,Winterhalter, Peter

, p. 1068 - 1072 (2007/10/02)

HRGC and HRGC-MS identifications of glycosidically bound Riesling leaf constituents were achieved after extraction with MeOH, Amberlite XAD-2 adsorption, and subsequent enzymatic hydrolysis of the glycoconjugates.Among the enzymatically liberated aglycons 23 bound C13 norisoprenoids were identified.With the aid of multilayer coil countercurrent chromatography (MLCCC) five major C13 glycosides were purified, and their structures were elucidated by high-field NMR, i.e., the β-D-glucopyranosides of vomifoliol, 4,5-dihydrovomifoliol, 3-hydroxy-5,6-epoxy-β-ionone, grasshopper ketone, and 3-oxo-megastigman-9-ol.The latter glucoside with a saturated megastigmane skeleton is reported here for the first time.In addition, the β-D-glucopyranosides of benzyl alcohol and raspberry ketone have been isolated.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 54835-70-0